R
Ralph B. D'Agostino
Researcher at Wake Forest University
Publications - 1336
Citations - 250792
Ralph B. D'Agostino is an academic researcher from Wake Forest University. The author has contributed to research in topics: Framingham Heart Study & Framingham Risk Score. The author has an hindex of 226, co-authored 1287 publications receiving 229636 citations. Previous affiliations of Ralph B. D'Agostino include VA Boston Healthcare System & University of Illinois at Urbana–Champaign.
Papers
More filters
Journal Article
The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study
TL;DR: Differences were noted in the risk profiles for various manifestations of cardiovascular disease (CVD) that occurred before the age of 65 during the first 30 years of follow-up of the 5070 subjects of the original Framingham cohort, highlighting the need for future studies to distinguish better between those factors that precipitate cardiovascular events and those that relate to the pathogenesis of the underlying atherosclerosis.
Journal ArticleDOI
Disparities in HbA1c Levels Between African-American and Non-Hispanic White Adults With Diabetes: A meta-analysis
Julienne K. Kirk,Ralph B. D'Agostino,Ronny A. Bell,Leah Passmore,Denise E. Bonds,Andrew J. Karter,K.M. Venkat Narayan +6 more
TL;DR: In this paper, a comparison of HbA 1c (A1C) levels between African Americans and non-Hispanic whites was evaluated, and a meta-analysis revealed the standard effect to be 0.31 (95% CI 0.39-0.25).
Journal ArticleDOI
Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.
Andrew G. Bostom,Halit Silbershatz,Irwin H. Rosenberg,Jacob Selhub,Ralph B. D'Agostino,Philip A. Wolf,Paul F. Jacques,Peter W.F. Wilson +7 more
TL;DR: Elevated nonfasting plasma tHcy levels are independently associated with increased rates of all-cause and CVD mortality in the elderly.
Journal ArticleDOI
Pulse pressure and risk of new-onset atrial fibrillation
Gary F. Mitchell,Ramachandran S. Vasan,Michelle J. Keyes,Helen Parise,Thomas J. Wang,Martin G. Larson,Ralph B. D'Agostino,William B. Kannel,Daniel Levy,Emelia J. Benjamin +9 more
TL;DR: Pulse pressure is an important risk factor for incident AF in a community-based sample and further research is needed to determine whether interventions that reduce pulse pressure will limit the growing incidence of AF.
Journal ArticleDOI
Estimating treatment effects using observational data.
TL;DR: Observational, nonrandomized studies have a role when RCTs are not available, and, even when they are available, to quantify effectiveness and other real world experiences and to adjust for pretreatment imbalances.